Publication:
Computational approaches for the study of serotonin and its membrane transporter SERT: Implications for drug design in neurological sciences

dc.contributor.authorJ. Pratuangdejkulen_US
dc.contributor.authorB. Schneideren_US
dc.contributor.authorJ. M. Launayen_US
dc.contributor.authorO. Kellermannen_US
dc.contributor.authorP. Maniveten_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherUniversite Paris Descartesen_US
dc.contributor.otherHopital Lariboisiere AP-HPen_US
dc.date.accessioned2018-07-12T02:16:23Z
dc.date.available2018-07-12T02:16:23Z
dc.date.issued2008-12-01en_US
dc.description.abstractSerotonin (5-hydroxytryptamine, 5-HT), a monoamine neurotransmitter of the central nervous and peripheral systems (CNS), plays a critical role in a wide variety of physiological and behavioral processes. In the serotonergic system, deregulation of the tightly controlled extracellular concentration of 5-HT appears to be at the origin of a host of metabolic and psychiatric disorders. A key step that regulates 5-HT external level is the re-uptake of 5-HT into cells by the 5-HT transporter (SERT), which is besides the target of numerous drugs interacting with the serotonergic system. Therapeutic strategies have mainly focused on the development of compounds that block the activity of SERT, for instance reuptake inhibitors (e.g. tricyclics, "selective" serotonin reuptake inhibitors) and in the past, specific substrate-type releasers (e.g. amphetamine and cocaine derivatives). Today, generation of new drugs targetting SERT with enhanced selectivity and reduced toxicity is one of the most challenging tasks in drug design. In this context, studies aiming at characterizing the physicochemical properties of 5-HT as well as the biological active conformation of SERT are a prerequisite to the design of new leads. However, the absence of a high-resolution 3D-structure for SERT has hampered the design of new transporter inhibitors. Using computational approaches, numerous efforts were made to shed light on the structure of 5-HT and its transporter. In this review, we compared several in silico methods dedicated to the modeling of 5-HT and SERT with an emphasis on i) quantum chemistry for study of 5-HT conformation and ii) ligand-based (QSAR and pharmacophore models) and transporter-based (homology models) approaches for studying SERT molecule. In addition, we discuss some methodological aspects of the computational work in connection with the construction of putative but reliable 3D structural models of SERT that may help to predict the mechanisms of neurotransmitter transport. © 2008 Bentham Science Publishers Ltd.en_US
dc.identifier.citationCurrent Medicinal Chemistry. Vol.15, No.30 (2008), 3214-3227en_US
dc.identifier.doi10.2174/092986708786848523en_US
dc.identifier.issn09298673en_US
dc.identifier.other2-s2.0-61549119818en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/18825
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=61549119818&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleComputational approaches for the study of serotonin and its membrane transporter SERT: Implications for drug design in neurological sciencesen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=61549119818&origin=inwarden_US

Files

Collections